Share Email Print

Proceedings Paper

Immediate and long-term efficacy and safety of photodynamic therapy with Photolon (Fotolon): a seven-year clinical experience
Author(s): Yuri P. Istomin; Michael A. Kaplan; Siarhei V. Shliakhtsin; Tatsiana P Lapzevich; Dmitriy A. Cerkovsky; Ludmila N. Marchanka; Alexander S. Fedulov; Tatsiana V. Trukhachova
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

The purpose of the present study was to summarize data on the long-term efficacy of photodynamic therapy (PDT) with Photolon in patients with malignant tumors of various types and localizations. The data obtained show that PDT with Photolon is a highly effective therapeutic modality for the treatment of skin tumors, cervical intraepithelial neoplasias, lung cancers, disseminated forms of melanoma, primary and metastatic brain tumors, several ophthalmologic diseases. This paper provides a review of most illustrative studies of the application of PDT with Photolon for the treatment of different oncological and non-oncological diseases performed in leading clinical centers of the Republic of Belarus and Russia.

Paper Details

Date Published: 13 July 2009
PDF: 8 pages
Proc. SPIE 7380, Photodynamic Therapy: Back to the Future, 73806V (13 July 2009); doi: 10.1117/12.823840
Show Author Affiliations
Yuri P. Istomin, N.N. Alexandrov National Cancer Ctr. of Belarus (Belarus)
Michael A. Kaplan, Medical Radiology Research Ctr. (Russian Federation)
Siarhei V. Shliakhtsin, RUE Belmedpreparaty (Belarus)
Tatsiana P Lapzevich, N.N. Alexandrov National Cancer Ctr. of Belarus (Belarus)
Dmitriy A. Cerkovsky, N.N. Alexandrov National Cancer Ctr. of Belarus (Belarus)
Ludmila N. Marchanka, Byelorussian State Medical Univ. (Belarus)
Alexander S. Fedulov, Byelorussian State Medical Univ. (Belarus)
Tatsiana V. Trukhachova, RUE Belmedpreparaty (Belarus)

Published in SPIE Proceedings Vol. 7380:
Photodynamic Therapy: Back to the Future
David H. Kessel, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?